SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003465
Filing Date
2021-11-08
Accepted
2021-11-08 16:12:05
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-20210930.htm   iXBRL 10-Q 2640129
2 EX-31.1 allk-ex31_1.htm EX-31.1 20378
3 EX-31.2 allk-ex31_2.htm EX-31.2 20401
4 EX-32.1 allk-ex32_1.htm EX-32.1 11208
5 EX-32.2 allk-ex32_2.htm EX-32.2 11227
  Complete submission text file 0000950170-21-003465.txt   8620827

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20210930_lab.xml EX-101.LAB 364420
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allk-20210930_def.xml EX-101.DEF 122224
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allk-20210930_cal.xml EX-101.CAL 42963
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20210930.xsd EX-101.SCH 37396
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20210930_pre.xml EX-101.PRE 259349
11 EXTRACTED XBRL INSTANCE DOCUMENT allk-20210930_htm.xml XML 1804886
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 211388066
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences